Swedish Orphan Biovitrum AB - Company & Market Research Reports

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.

From
From
From
From
From
From
Ulcerative Colitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 542 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 482 Pages
From
From
From
From
Factor IX -Pipeline Insight, 2018 - Product Thumbnail Image

Factor IX -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
From
From
Loading Indicator
adroll